chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a respiratory therapist refers to one among three unspecified patient, age and gender were unknown. Medical history was not reported. The respiratory therapist informed that between 01-FEB-2014 through 31-MAY-2014 the patient was vaccinated with GARDASIL 120Y, injection, lot number T007850 expiration date 07-APR-2016 (route, strength and dosage were not reported), which was improperly stored. Concomitant therapy was not reported. No adverse effects were reported. No product quality complaint (PQC) filed. The action taken was assessed as not applicable. The causality was assessed as not related to the suspect therapy. Follow up information has been received. Lot number T007850 is an invalid lot numbers for GARDASIL.  This is one of several reports received from the same reporter. Additional information has been requested.
pt recv vax 19DEC95 & 21DEC95 pt devel redness & soreness on the opposite site of the arm from the inj site;pt was advised to treat w/cool compresses & DPH;
grade 2 amount of redness; hurt; warm to the touch; itching; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (hurt), INJECTION SITE WARMTH (warm to the touch), INJECTION SITE PRURITUS (itching) and INJECTION SITE ERYTHEMA (grade 2 amount of redness) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced INJECTION SITE PAIN (hurt), INJECTION SITE WARMTH (warm to the touch) and INJECTION SITE PRURITUS (itching). On 19-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (grade 2 amount of redness). The patient was treated with LORATADINE (CLARITIN [LORATADINE]) at a dose of UNK UNK, qd. On 14-Jan-2021, INJECTION SITE PAIN (hurt), INJECTION SITE WARMTH (warm to the touch) and INJECTION SITE PRURITUS (itching) had resolved. At the time of the report, INJECTION SITE ERYTHEMA (grade 2 amount of redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.  Treatment medication included claritin every day. She's not sure if she should take Benadryl or try ice pack.
I still have pain/ still have stabbing pain; Had hand print size rash in the front under breast and the same on back right side; Had both shots. I got Shingles in August of 2021/ suspected vaccination failure; I got Shingles in August of 2021; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. In AUG-2021, an unknown time after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (Verbatim: Had both shots. I got Shingles in August of 2021/ suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: I got Shingles in August of 2021). On an unknown date, the patient experienced pain (Verbatim: I still have pain/ still have stabbing pain) (serious criteria GSK medically significant) and rash (Verbatim: Had hand print size rash in the front under breast and the same on back right side). The outcome of the vaccination failure was unknown and the outcome of the shingles and rash were not reported and the outcome of the pain was not resolved.   It was unknown if the reporter considered the vaccination failure, shingles, pain and rash to be related to Shingles vaccine and Shingles vaccine.     It was unknown if the company considered the vaccination failure, shingles, pain and rash to be related to Shingles vaccine and Shingles vaccine.   Additional Information: GSK Receipt Date: 26-MAR-2023 This case was reported by patient via interactive digital media. The patient had both shots and still had pain and had not been able to wear a bra since he/she got shingles.  The patient had a hand print size rash in the front under his/her breast and the same on his/her back right side.  The patient still had stabbing pain. This case was considered as suspected vaccination failure since the details regarding the time to onset and laboratory confirmation of shingles were unknown at the time of reporting. Follow up was not possible, as no contact details were available.
This spontaneous report as received from a certificated medical assistant refers to an unspecified number of patients of unknown age and gender. Concurrent conditions and medical history were not reported. On an unknown date, the patients were vaccinated with doses of VAQTA (lot # K005323, expiration date 10-FEB-2017) (Route and dose were not provided), which had temperature excursion. Concomitant medication were not reported. No adverse effects reported. This is one of several reports from the same source. Additional information has been requested.
One day after my 2nd Shingles shot, I started to be tired and nauseated.  I had a large emesis and went to bed and felt much better in the morning.  I also have reddening around the vaccination site.
COVID-19 / given COVID 19 Treatment; COVID-19 / given COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 41-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 22Nov2021 at 17:30 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 40 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The patient has no known allergies. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset May2022, outcome "unknown" and all described as "COVID-19 / given COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on plausible dose -event relationship post vaccination and no other alternate explanation the causal role of BNT162B2 cannot be excluded for the reported LOE events.
Hair coming out toes took 6 months then boom; Initial information received on 24-Jan-2021 regarding an unsolicited valid non-serious case received from a consumer or non-healthcare professional.  This case involves a patient (age and gender not reported) who experienced hair coming out toes took 6 months then boom (hair growth abnormal), while he/she received INFLUENZA VACCINE.  Medical history, past medical treatment, past vaccination, concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) [lot number and expiry date not reported] via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed non-serious hair coming out toes took 6 months then boom (hair growth abnormal) (unknown latency) following the administration of INFLUENZA VACCINE.  Details of laboratory data not reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, the event outcome reported as unknown for event.  There will be no information available on batch number for this case.
7 days after my first shot into my left arm. my pointer finger turned white / purple and was tingling numb and cold. that would come and go and then about day 14 my middle finger experienced the same thing as my pointer got worse and more painful. , by day 20 my ring finger started to experience it but never as bad as the pointer and middle.  I went to the DR at that time and it was presenting as  Raynaud's. and i was prescribed amLODIPine (NORVASC).   after a week of this seams not to help.
pt recvd vax; fever 100-100.6; excessive somnolence for 48 hrs after vax;
Initial report received from a health care professional on 30 January 2014. A female patient, whose demographic details including age, date of birth and initials not reported had received a dose of FLUZONE (dose number, lot number, route and site of vaccination not reported) on an unspecified date. The patient had received the vaccine in the tendon of the rotator cuff and the patient had experienced inflammation of her tendon. Corrective treatment and laboratory details were not reported. At the time of this report the outcome of the event was unknown. Documents held by sender: none.  Follow up information was received on 07 April 2014: It was updated that the patient's date of birth was on 17 January 1997 and the age was 17 years at the time of the report.
Approximately 2 1/2 to 3 hours after vaccines mom noted a loud hiccup noise then a head and chest thrust with a "nerve twitch" in his face lasted a few seconds. It was occurring every few minutes for about 30-60 minutes. Baby was admitted for observation. Had normal 4 hour EEG BMP, CBC, U/A normal. No further episodes.
Information has been received from a nurse concerning a 25 year old female with no pertinent medical history or history of drug allergies or reaction who in June 2006, was vaccinated with the first dose of VARIVAX (Merck). In April 2008, the patient was vaccinated with the second dose of VARIVAX (Merck). The vaccinations were affiliated with another practice. There was no concomitant medication. In May 2008, antibody titers were drawn and were found to be negative. It was unknown if the patient sought medical attention or not. Additional information has been requested.
Allergic reaction from the chicken pox booster.  Hives that were burning hot down my daughter's arm.  This lasted all day and through the night.  She had no difficulty breathing or dizziness.  Benadryl was given along with hydrocortizone cream.  The vaccine was given to her as an infant with no reaction, she then had
Immediate swelling at injection site. Turned hard and was tender when I pressed on the bump.
Pt was signed in for a flu vaccine. I verified patient and documented flu vaccine visit. After I documented, I opened the fridge and took out a Moderna vial. The patient prior had a Moderna booster so I was in the habit of giving the Moderna booster the majority of the morning. I took out the Moderna vial and drew up the Moderna booster dose of 0.25ml. I injected the patient and after I realized I gave the wrong vaccine in which I told the patient. I was very apologetic about the incident. The patient was upset but did not appear to be too distraught at the time. The patient still wanted her flu vaccine and her flu vaccine was then given and the patient left.
Information has been received from a certified medical assistant concerning a patient who was vaccinated with a dose of Zostavax (Oka/Merck).  On an unspecified date the patient developed a shingles-type rash.  At the time of the report the patient's status was unknown.  A product quality complaint was not involved.  Additional information has been requested. 06/24/2008 This is in follow-up to report(s) previously submitted on 3/26/2008. Additional information is not expected.
Swelling; Itchy; Hardness; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Swelling), PRURITUS (Itchy) and INJECTION SITE INDURATION (Hardness) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced SWELLING (Swelling), PRURITUS (Itchy) and INJECTION SITE INDURATION (Hardness). At the time of the report, SWELLING (Swelling), PRURITUS (Itchy) and INJECTION SITE INDURATION (Hardness) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
This spontaneous report as received from a Licensed Practical Nurse refers to a patient of 12 months old infant patient and unknown gender. On 03-SEP-2014 the patient was vaccinated with a dose of MMRII (lot H020255, expiration date not reported) (dose, route, were not reported). No adverse effect was reported. The outcome of events reported was unknown. No product quality complaint was involved. This is one of several reports received from the same source. Additional information has been requested.
My son received the Varicella vaccine a little after his first birthday and all seemed well. This summer, he came down with a bad case of shingles on his left arm and he has never had nor been exposed to chickenpox. When we took him to the doctor for treatment, he said the vaccine is made from weakened chickenpox and once introduced to the body, it never leaves. Shingles is reactivation of dad chicken pox virus. He is okay now, but it was a painful illness. His fever was 101 during worst part an in all it took 2..5 weeks to get better. We used supportive care. Calamine lotion and pain medicine, etc.
MMR received on 12/10/2007, on 12-15-07 pt experienced a raised red rash beginning on her forehead->neck ->chest, mild nausea.
It started with severe nasal congestion. I went to my doctor for nasal spray. From there, I developed a little cough. I also was experiencing some chest pressure and some chest pain. At that point, I decided to take an at home COVID-19 test which was positive. I went to the emergency room for my chest pain. I had extreme fatigue, body aches and diarrhea. This lasted for 5 days and I took Paxlovid. I still have a lingering cough.
The main issue was that I went into atrial flutter, pericardial effusion; fluid in the heart as well as fluid in the lungs. I had extreme fatigue and weakness. Nausea, just sick in general. I was gaining weight very fast at the time. After the vaccination, I experienced a lot of allergy symptoms. A couple weeks after the vaccination, I was exposed to COVID, and I somehow did not get it. I thought I had it because I was experiencing a lot of allergy symptoms. I got tested and came back negative. After that I was experiencing allergy symptoms until I finally ended up in the hospital with the cardiac issue. And I waited a week before I went to the hospital and took cardiac medication to try to stop it. On 02/17/2022, I went to the hospital. Felt like I got worse in the hospital when my blood pressure dropped. They put me on nebivolol low dose 2.5mg and Eliquis. They were going to do a cardioversion because I didn't want to be in a fib constantly. They told me to go to a local cardiologist. My heart rate is all over the place and I'm pretty sure I'm in persistent a-fib.
Narrative:  COVID infection following COVID vaccine series 03/29, Pfizer, dose #1 04/19, Pfizer, dose #2 09/13 pt cc: weakness, bodyache, no appetite, confusion: unknown 09/20 pt admit to medicine cc: weakness and decrease PO intake x 7 days dx: COVID 19 infection LOS: 4 days 09/20 LIPASE: 30 09/20 COVID-19 ANTIGEN (BINAX): DETECTED 09/20 LACTIC ACID: 1.95 09/20 PT/INR 15.3/1.37 09/20 TROPONIN I: 0.042 09/20 DDIMER: 1.17 09/20 FERITIN: 1227.2 09/20 LDH: 429.9 09/20 CRP: 5.535 09/20 FIBRINOGEN: 326 09/20 BNP result: <10.0 09/20 SARS-COV-2 IgG result: 0.47 09/20 SARS-COV-2 TOTAL AB, SPIKE result: .2500.00 09/20 CXR impression: No focal consolidation. 09/21 CTA PE impression: 1. No pulmonary embolus to the subsegmental level. 2. Imaging findings consistent with ongoing COVID pneumonitis. No pleural effusion. ABDOMEN/PELVIS: Imaging findings consistent with a combination of chronic cystitis and bladder outlet obstructive disease. Urinary bladder is mostly collapsed about an indwelling Foley catheter balloon. No imaging findings of pyelitis, pyelonephritis or renal abscess. Marked prostatomegaly with changes of benign prostatic hyperplasia. Normal seminal vesicles. Remainder of findings as above. 09/21 COVID swab, result: detected 09/21 FIBRINOGEN: 449 09/21 DDIMER: 0.79 09/21 ESR: 45 09/21TROPONIN I: 0.025 09/22 FIBRINOGEN: 399 09/22 DDIMER: 0.63 09/22 ESR: 24 09/23 FIBRINOGEN: 336 09/23 DDIMER: 0.59 09/23 ESR: 5 09/24 FIBRINOGEN: 321 09/24 DDIMER 0.65 09/24 ESR:24
This spontaneous report as received from a registered nurse via a company representative refers to a 55 year old female patient with allergy to Chantix (developed hypertension) and penicillin (developed swelling). The reporter reported the patient received one dose of PNEUMOVAX23 (lot# unspecified) (dose, route, frequency and indication unspecified). Concomitant therapies included Xanax and Alprazolam. Then patient developed swelling and discomfort in the upper left arm around the injections site, and erythema over "a good portion" of the upper arm on 14-NOV-2013. No treatment was given for the adverse event. Non lab diagnostics studies performed. The patient had sought medical attention by doctor's visit. The patient's present status was reported as recovering. Additional information has been requested.
Dizzy spells, pressure behind eyes like a band across head, vertigo, nausea 2 days after vaccine.
This spontaneous report as received from a certified medical assistant refers to a 4 year old patient of an unknown gender. The patient's medical history, drug reactions or allergies and concomitant medications were not reported. On an unknown date, the patient was vaccinated with VARIVAX (Merck) unknown route and strength (lot # K015970 with expiration date 23-SEP-2016 or lot # K021847 with expiration date 03-NOV-2016 or lot # L001335 with expiration date of 13-JAN-2017) which were exposed to temperatures outside of the recommended range. There was no adverse event reported. The reporter could not break out which specific lot number of vaccine was administered to the patient. This is one of the several reports received from the same reporter. Additional information has been requested.
Cellulitis at injection site of PNEUMOVAX - was prescribed doxycycline 100 mg for cellulitis.
6 DAYS AFTER VACCINATION PATIENT BEGAN TO EXPERIENCE SWELLING, REDNESS, ITCHING AND WARMTH AT INJECTION SITE.  SHE MEASURED THE LESION AS 2.5X3 INCHES.
red rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (red rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced RASH ERYTHEMATOUS (red rash). At the time of the report, RASH ERYTHEMATOUS (red rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment drugs included no concomitant drugs included
This case was reported by a pharmacist via call center representative and described the occurrence of pain in arm in a 29-year-old female patient who received ENGERIX B adult (batch number B39CM, expiry date 3rd February 2020). On an unknown date, the patient received ENGERIX B adult. On an unknown date, unknown after receiving ENGERIX B adult, the patient experienced pain in arm and inappropriate age at vaccine administration. On an unknown date, the outcome of the pain in arm was recovered/resolved and the outcome of the inappropriate age at vaccine administration was unknown. It was unknown if the reporter considered the pain in arm to be related to ENGERIX B adult. Additional details were provided as follows: The age at vaccination was not reported. Health Care Professional reported that the patient inadvertently received an adult dose of ENGERIX-B as 1st dose in series, which led to inappropriate age at vaccine administration. No further information was reported regarding the event.
I exp 103 fever for 3 days after Dose 1. My normal body temp is 99.8 and left arm had swollen (size of little tennis ball, hard,hot). I had to continue to turn the lights off due to headaches. I started to have involuntary gasps and blood oxygen level was going down at night. After the fever was gone I felt 3-4 days later. I followed up with Pulmonologist and scheduled for MRI.
experiencing fatigue; mild headache; slight fever no more than 100°F during 48 hours; This spontaneous case was reported by a physician and describes the occurrence of FATIGUE (experiencing fatigue), HEADACHE (mild headache) and PYREXIA (slight fever no more than 100°F during 48 hours) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027L21A, 011F21A and 014M20A) for COVID-19 vaccination.     Patient did not have any allergies related to medications, food and other products. Patient never tested positive or diagnosed with COVID.  Concurrent medical conditions included Enlarged prostate (Condition was worsening.) since 1990, Blood pressure high and High cholesterol. Concomitant products included WARFARIN, ATORVASTATIN and HYDROCHLOROTHIAZIDE, LISINOPRIL (ZESTORETIC) for an unknown indication.   On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (experiencing fatigue) and HEADACHE (mild headache). an unknown date, the patient experienced PYREXIA (slight fever no more than 100°F during 48 hours). At the time of the report, FATIGUE (experiencing fatigue), HEADACHE (mild headache) and PYREXIA (slight fever no more than 100°F during 48 hours) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Pyrexia: no more than 100°F.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient had current condition of prosthetic mitral valve (no change in condition).  No treatment medications was reported.   This case was linked to MOD-2022-651167, MOD-2022-651186 (Patient Link).
Site red & irritated, became infected cleaned w/alcohol put neopsorin on it. never healed took 7 days antibiotic, still didn't heal for 4 weeks. at 5 weeks finally looks better small scab, scar, and hard bump where it is healed.
On 3/12/01 pt had a 40mm diameter reddened area on right vastus lateralis area which also has many small red dots within the area. Mother reports a low-grade fever, appears to have pain with walking. On 3/15/01, mother reports rash almost gone.